SMITHA MELLACHERUVU
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology BRONX, NY NPI 1548330970
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NY PFIZER INC. All categories
General Payments — all program years on this page
$1,235.54
- Category: General Payments
- Program years: PY2018–2024
- Record count: 56
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $848.36 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $770.39 | 41 |
| Education | $77.97 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $116.60 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.15 | 4 |
| SEAGEN INC. | $77.97 | 1 |
| Acerta Pharma LLC | $68.80 | 3 |
| Merck Sharp & Dohme Corporation | $63.09 | 4 |
| Genmab U.S., Inc. | $41.66 | 1 |
| EISAI INC. | $41.62 | 2 |
| Celgene Corporation | $40.65 | 2 |
| ARRAY BIOPHARMA INC | $38.94 | 2 |
| Astellas Pharma US Inc | $35.78 | 2 |
| ABBVIE INC. | $32.96 | 2 |
| Daiichi Sankyo Inc. | $29.92 | 2 |
| ADC Therapeutics America, Inc. | $22.80 | 1 |
| Geron Corporation | $21.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.80 | 1 |
| Gilead Sciences, Inc. | $19.92 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.80 | 1 |
| Lilly USA, LLC | $16.35 | 1 |
| Kite Pharma, Inc. | $16.32 | 1 |
| Incyte Corporation | $14.01 | 1 |
| GENZYME CORPORATION | $13.79 | 1 |
| SOBI, INC | $13.58 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.